Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2+ early breast cancer (EBC).
Fernandez-Martinez A, Tanioka M, Ahn SG, Zagami P, Pascual T, Rediti M, Tang G, Hoadley KA, Venet D, Rashid NU, Spears PA, Di Cosimo S, de Azambuja E, Choudhury A, Rastogi P, Islam MN, Cortes J, Llombart-Cussac A, Swain SM, Sotiriou C, Prat A, Perou CM, Carey LA. Fernandez-Martinez A, et al. Among authors: di cosimo s. Ann Oncol. 2024 Dec 18:S0923-7534(24)04989-5. doi: 10.1016/j.annonc.2024.12.010. Online ahead of print. Ann Oncol. 2024. PMID: 39706338 Free article.
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.
Rediti M, Venet D, Joaquin Garcia A, Maetens M, Vincent D, Majjaj S, El-Abed S, Di Cosimo S, Ueno T, Izquierdo M, Piccart M, Pusztai L, Loi S, Salgado R, Viale G, Rothé F, Sotiriou C. Rediti M, et al. Among authors: di cosimo s. Nat Commun. 2024 Nov 29;15(1):10402. doi: 10.1038/s41467-024-54621-3. Nat Commun. 2024. PMID: 39613746 Free PMC article.
From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer.
Bernasconi A, Zanga A, Lucas PJF, Scutari M, Di Cosimo S, De Santis MC, La Rocca E, Baili P, Cavallo I, Verderio P, Ciniselli CM, Pizzamiglio S, Blanda A, Perego P, Vallerio P, Stella F, Trama A, The Ada Working Group. Bernasconi A, et al. Among authors: di cosimo s. Cancers (Basel). 2024 Oct 29;16(21):3643. doi: 10.3390/cancers16213643. Cancers (Basel). 2024. PMID: 39518081 Free PMC article.
Erratum: Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Albiñana CB, Pallocca M, Fenton H, Sopwith W, Eden CV, Akre O, Auranen A, Bocquet F, Borges M, Calvo E, Corkett J, Di Cosimo S, Gentili N, Guérin J, Jor S, Kazda T, Kolar A, Kuschel T, Lostes MJ, Paratore C, Pedrazzoli P, Petrovic M, Raid J, Roche M, Schatz C, Thonnard J, Tonon G, Traverso A, Wolf A, Zedan AH, Mahon P. Albiñana CB, et al. Among authors: di cosimo s. Appl Clin Inform. 2024 Aug;15(4):e1. doi: 10.1055/s-0044-1792139. Epub 2024 Nov 4. Appl Clin Inform. 2024. PMID: 39496321 Free article. No abstract available.
The role of radiation therapy in the multidisciplinary management of male breast cancer: A systematic review and meta-analysis on behalf of the Clinical Oncology Breast Cancer Group (COBCG).
Colciago RR, Lancellotta V, De Santis MC, Bonzano E, De Rose F, Rocca E, Meduri B, Pasinetti N, Prisco A, Gennari A, Tramm T, Di Cosimo S, Harbeck N, Curigliano G, Poortmans P, Meattini I, Franco P. Colciago RR, et al. Among authors: di cosimo s. Crit Rev Oncol Hematol. 2024 Dec;204:104537. doi: 10.1016/j.critrevonc.2024.104537. Epub 2024 Oct 23. Crit Rev Oncol Hematol. 2024. PMID: 39454738 Free article.
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].
de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, Kelly CM, Lombard J, El-Abed S, Choudhury A, Korde L, Vicente M, Chumsri S, Rodeheffer R, Ellard SL, Wolff AC, Holtschmidt J, Lang I, Untch M, Boyle F, Xu B, Werutsky G, Tujakowski J, Huang CS, Baruch NB, Bliss J, Ferro A, Gralow J, Kim SB, Kroep JR, Krop I, Kuemmel S, McConnell R, Moscetti L, Knop AS, van Duijnhoven F, Gomez H, Cameron D, Di Cosimo S, Gelber RD, Moreno-Aspitia A. de Azambuja E, et al. Among authors: di cosimo s. ESMO Open. 2024 Nov;9(11):103938. doi: 10.1016/j.esmoop.2024.103938. Epub 2024 Oct 17. ESMO Open. 2024. PMID: 39418883 Free PMC article. Clinical Trial.
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Albiñana CB, Pallocca M, Fenton H, Sopwith W, Eden CV, Akre O, Auranen A, Bocquet F, Borges M, Calvo E, Corkett J, Di Cosimo S, Gentili N, Guérin J, Jor S, Kazda T, Kolar A, Kuschel T, Lostes MJ, Paratore C, Pedrazzoli P, Petrovic M, Raid J, Roche M, Schatz C, Thonnard J, Tonon G, Traverso A, Wolf A, Zedan AH, Mahon P. Albiñana CB, et al. Among authors: di cosimo s. Appl Clin Inform. 2024 Aug;15(4):743-750. doi: 10.1055/s-0044-1788331. Epub 2024 Sep 11. Appl Clin Inform. 2024. PMID: 39260412
209 results